Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

RioCan Real Estate Investment Trust T.REI.UN

Alternate Symbol(s):  RIOCF

RioCan Real Estate Investment Trust is a Canada-based real estate investment trust. The Company owns, manages, and develops retail-focused mixed-use properties. Its portfolio includes leasing, development, and residential. The Company’s properties are held by various tenants, such as grocery, pharmacy, liquor, personal services, and specialty and value retailers. The Company’s portfolio is comprised of approximately 192 properties with an aggregate net leasable area of approximately 33.6 million square feet, including office, residential rental and 10 development properties. Its properties include 1293 Bloor Street West, 145 Woodbridge Avenue, 1556 Bank Street, 1650 - 1660 Carling Avenue, 1860 Bayview, 1910 Bank St, 1946 Robertson Road, 2323 Yonge Street, 2329 Yonge Street, 2335 Boul Lapiniere, 2345 Yonge Street, 2422 Fairview Street, 2453 Yonge Street, 279 Rue St. Charles, 2950 Carling Avenue, and 2955 Bloor Street West.


TSX:REI.UN - Post by User

Comment by gasholeon Dec 22, 2020 4:22pm
60 Views
Post# 32163126

RE:RE:RE:RE:RE:RE:RE:THE BIG SHORT

RE:RE:RE:RE:RE:RE:RE:THE BIG SHORTI will wait for an immunologist to confirm until that time it's all guesswork unless one of you guys is an expert in virology.... the nightmare scenario would be the vaccine does not work against this strain and the virus continues to mutate into other strains can you imagine? The best case scenario is the vaccine works against multiple strains of mutation including the one that's in the UK right now and supposedly around the world according to the experts on this board.... I will wait and see what the results are in two weeks I guess
CANCDN wrote: Agree, the issue is this time, it was publicized for the click bait media to run with. The same exact tests have been conducted for every other strain as well, but the other groups didnt have Boris yapping. 

It also happens many times during flu season.

Sapho wrote:
CANCDN wrote: They test the vaccine against EVERY SINGLE mutation. This is routine. Its only news because Boris went on a rampage. This mutation has been circulation since September. 

Sapho wrote:
CANCDN wrote: Yup and people are stupid if they believe that. Mutations dont cause a 95% effective vaccine to go to 0%. In fact, the mutation (this is #21 by the way that is being tested against the vaccine) is JUST as likely to INCREASE efficacy as it is to decrease efficacy. Its not an all or nothing proposition. It might come back that the vaccine is 5% LESS effective , or it could be 5% MORE effective (unlikely 100%). 

Keep shorting.

not one crediable vaccinologist actually believes this will affect the vaccine what so ever. all 20+ previous mutations are easily managed by the vaccine. Will mRNA vaccine manufacture slightly adjusted formula,,, possibily, but same happens every year with flu vaccines, and those are only 60% effective at best. 

Keep up the panic porn

BlueGuitar1 wrote: Only a fool ignores "thenewsnake".  He has some good insights.

Concerning what he just said, the mutation is in the receptor binding location which could be very bad for the new vaccines.  Specifically it is the animo-acid in the 501 position and has changed from Asparagine (N) to Tyrosine (Y).  The mutation is therefore called N501Y, or N to Y in position 501.  If there is another mutation near this position, the new vaccine probably will not work.  This mutation is in Brazil, Australia, UK, Denmark, and Netherlands now.  It is probably in Canada. I will still say that we will have a tough next 6 months.  The vaccine will not help in the first and second quarters. 

Hope that helps a bit in making your own financial decisions.  Do your own DD. 

thenewsnake wrote:

Is definitely on this turd- drifting lower by the second.  Watch a headline come out "vaccine proven not to be effective against new strain" and BAM just like that we're down an additional 20%!!!!!!!!!!!!

 

 


So why the companies are investigating theeffectivness of vaccine on the new strain. Please dont call people stupid. Let drug companies do  their due deligence and we will find out soon. 

OK moron ??? lol 
 

 


This is WSJ 

The Pfizer-BioNTech vaccine, which has now been administered to over one million people world-wide, is highly likely to be effective against the new coronavirus variant, Dr. Sahin said. It will take about two weeks to confirm that through testing, he said, adding that the company will publish the resulting data.

“We have scientific confidence that the vaccine might protect, but we will know it only when the experiment is done,” he said.






<< Previous
Bullboard Posts
Next >>